PVI
REGN icon

Pine Valley Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Pine Valley Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.98M Sell
4,783
-159
-3% -$108K 0.12% 166
2026
Q1 		$3.82M Sell
4,942
-970
-16% -$743K 0.18% 131
2025
Q4 		$4.56M Sell
5,912
-591
-9% -$401K 0.21% 111
2025
Q3 		$3.66M Sell
6,503
-1,606
-20% -$908K 0.18% 129
2025
Q2 		$4.26M Buy
8,109
+1,747
+27% +$975K 0.24% 109
2025
Q1 		$4.04M Sell
6,362
-250
-4% -$172K 0.24% 111
2024
Q4 		$4.71M Buy
6,612
+1,309
+25% +$1.1M 0.28% 89
2024
Q3 		$5.57M Buy
5,303
+848
+19% +$944K 0.34% 73
2024
Q2 		$4.68M Buy
4,455
+626
+16% +$607K 0.31% 77
2024
Q1 		$3.69M Buy
3,829
+380
+11% +$361K 0.25% 94
2023
Q4 		$3.03M Buy
3,449
+536
+18% +$441K 0.22% 100
2023
Q3 		$2.4M Buy
2,913
+992
+52% +$780K 0.22% 110
2023
Q2 		$1.38M Buy
1,921
+53
+3% +$40.9K 0.14% 160
2023
Q1 		$1.17M Buy
+1,868
New +$1.41M 0.17% 118

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

Pine Valley Investments's REGN Position: Q2 2026 in Review

Pine Valley Investments reduced its Regeneron Pharmaceuticals (REGN) stake by 3.2% in Q2 2026, selling an estimated $108K and leaving 4,783 shares worth $2.98M. The position accounts for 0.12% of the portfolio, ranked #166.

Pine Valley Investments first reported a position in REGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.57M in Q3 2024. 627 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Pine Valley Investments held 4,783 shares of Regeneron Pharmaceuticals worth $2.98M as of Q2 2026.
  • Pine Valley Investments sold 159 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $108K.
  • Regeneron Pharmaceuticals made up 0.12% of Pine Valley Investments's portfolio in Q2 2026, its #166 holding.
  • Pine Valley Investments first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • Pine Valley Investments's Regeneron Pharmaceuticals position peaked at $5.57M in Q3 2024.
  • 627 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Pine Valley Investments's 13F filing for Q2 2026, filed 24 Jul 2026.